sweat gland carcinoma

sweat gland car·ci·no·ma

usually a solitary tumor, nodular and fixed to the skin and underlying structure, having slow growth for long periods followed by rapid growth and dissemination.

sweat gland car·ci·no·ma

(swet gland kahr'si-nō'mă)
Usually a solitary tumor, nodular and affixed to the skin and underlying structures, having slow growth for long periods followed by rapid growth and dissemination.
References in periodicals archive ?
Although vulvar sweat gland carcinoma is very rare, accounting for less than 1% of all malignant vulvar tumors, adenoid cystic carcinoma accounts for approximately 20% to 25% of all Bartholin gland malignancies.
Adenocarcinoma of the mammary-like glands of the vulva: a concept unifying sweat gland carcinoma of the vulva, carcinoma of supernumerary mammary glands and extramammary Paget's disease.
A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma.
16) They found a statistically significant infrequency of gross cystic disease fluid protein-15 in eccrine sweat gland carcinomas, a paucity of carcinoembryonic antigen in breast cancers, and an absence of estrogen receptor protein in salivary duct carcinomas.
Homologous carcinomas of the breasts, skin, and salivary glands: a histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma.
Demographics of Cutaneous Metastatic Breast Carcinoma (CMBC) and Sweat Gland Carcinoma (SGC) Cases Mean Age Case Group No.
Sweat gland carcinoma of the hand (malignant acrospiroma).
It is generally accepted that the first case of a sweat gland carcinoma was reported as early as 1865 by the renowned French pathologist Victor Andre Cornil.
Sentinel lymph node analysis in patients with sweat gland carcinoma.
16,31,32] Immunohistochemistry may provide useful information; in particular, diffuse positivity for CEA and negativity for gross cystic disease fluid protein 15 would favor the interpretation of primary sweat gland carcinoma over one of metastatic breast cancer.
Cornil as early as 1865,[1] sweat gland carcinomas were still surrounded by mystery at the beginning of the 1950s, because few cases had been described and these were not well documented.
Wick and coworkers (11) reported that gross cystic disease fluid protein 15 (BRST-2) was statistically significant in its lack of staining in eccrine sweat gland carcinomas as compared to ductal carcinomas of the breast.